News
As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building ...
Progyny (NASDAQ:PGNY – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a research report issued on Monday,Benzinga reports.
Shares of Progyny, Inc. (NASDAQ:PGNY – Get Free Report) have earned a consensus rating of “Hold” from the thirteen ratings firms that are presently covering the firm, MarketBeat reports.
Progyny, Inc. ( (PGNY)) has released its Q3 earnings. Here is a breakdown of the information Progyny, Inc. presented to its investors. Progyny, Inc. is a company that provides fertility, family bu ...
Progyny revealed that it's losing a major client. While the client name wasn't disclosed, it accounted for 12% of Progyny's total revenue in the first half of 2024. Progyny still expects its ...
Shares of Progyny (NASDAQ: PGNY) were crashing 30.1% lower as of 11:22 a.m. ET on Thursday. The steep decline came after the fertility benefits provider disclosed in a regulatory filing that it ...
Hosted on MSN10mon
Why Progyny Stock Dropped TodayShares of leading fertility benefits specialist Progyny (NASDAQ: PGNY) dropped 19% as of 1 p.m. EDT on Wednesday, according to data provided by S&P Global Market Intelligence. While Progyny beat ...
Progyny missed analysts' revenue expectations for the second quarter by a tiny margin. Making matters worse, the company cut sales growth guidance from 15% to 8.5% for 2024. Despite these ...
Progyny NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion ...
Within the last quarter, Progyny (NASDAQ:PGNY) has observed the following analyst ratings: In the last 3 months, 5 analysts have offered 12-month price targets for Progyny. The company has an ...
As of September 26, 2023, Progyny Inc (NASDAQ:PGNY) experienced a daily gain of 2.89%, despite a 3-month loss of 8.01%. With an Earnings Per Share (EPS) of $0.49, the question arises: is Progyny ...
Progyny PGNY shares are trading higher on Tuesday after the company reported better-than-expected Q4 results. Progyny reported quarterly earnings of $0.03 per share which beat the analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results